Literature DB >> 21439838

Tumor accumulation of ε-poly-lysines-based polyamines conjugated with boron clusters.

Masayuki Umano1, Kazuhiro Uechi, Takatoshi Uriuda, Sayuri Murayama, Hideki Azuma, Atsuko Shinohara, Young Liu, Koji Ono, Mitsunori Kirihata, Hironobu Yanagie, Takeshi Nagasaki.   

Abstract

Boron Neutron Capture Therapy (BNCT) is one of the potent cancer radiotherapies using nuclear reaction between (10)B atoms and the neutron. Whether BNCT will succeed or not depends on tumor selective delivery of (10)B compounds. ε-Poly-L-lysine is a naturally occurring polyamine characterized by the peptide linkages between the carboxyl and ε-amino groups of L-lysine. Because of high safety ε-PLL is applied practically as a food additive due to its strong antimicrobial activity. In this study, we focus on a development of a novel polymeric delivery system for BNCT using biodegradable ε-PLL conjugated with (10)B-containing clusters (BSH). This polymeric boron carrier will be expected to deliver safely and efficiently into tumor tissues based on Enhanced Permeability and Retention (EPR) effect. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439838     DOI: 10.1016/j.apradiso.2011.02.048

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  4 in total

1.  Synthesis and Applications of Perfunctionalized Boron Clusters.

Authors:  Jonathan C Axtell; Liban M A Saleh; Elaine A Qian; Alex I Wixtrom; Alexander M Spokoyny
Journal:  Inorg Chem       Date:  2018-02-21       Impact factor: 5.165

2.  PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.

Authors:  Wen Bao; Ran Liu; Yonglu Wang; Fei Wang; Guohua Xia; Haijun Zhang; Xueming Li; Haixiang Yin; Baoan Chen
Journal:  Int J Nanomedicine       Date:  2015-01-12

3.  Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation.

Authors:  Wen Bao; Ran Liu; Guohua Xia; Fei Wang; Baoan Chen
Journal:  Drug Des Devel Ther       Date:  2019-04-08       Impact factor: 4.162

4.  Bevacizumab and CCR2 Inhibitor Nanoparticles Induce Cytotoxicity-Mediated Apoptosis in Doxorubicin-Treated Hepatic and Non-Small Lung Cancer Cells.

Authors:  Ahmed A Abd-Rabou; Hanaa H Ahmed
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.